Medicine News and Research

RSS

Psychopharmacology expert calls for more mental health staffing at army bases

The recent shootings at the Ft. Hood, Texas army base, allegedly by an army psychiatrist, have placed much-needed focus on mental health care in the army. In an article published in the December issue of the journal CNS Spectrum, renowned psychopharmacology expert Stephen M. Stahl, MD, PhD, calls for increased mental health staffing at Fort Hood and other army bases.

14 Dec 2009

MHI launches new research program in heart failure

The Montreal Heart Institute (MHI) and its Foundation (MHIF) launched today the Carolyn and Richard J. Renaud Research Chair in Heart Failure, the first of its kind in Québec.

14 Dec 2009

Genentech announces Phase III study of Avastin in women treated with chemotherapy for advanced breast cancer

Genentech, Inc., a wholly owned member of the Roche Group, today announced results from a Phase III study (RIBBON 2) of Avastin® (bevacizumab) in women who had previously been treated with initial (first-line) chemotherapy for advanced HER2-negative breast cancer and needed additional (second-line) treatment.

14 Dec 2009

Hormone therapy: An important treatment option for post-menopausal women

In connection with the New York Times’ recent coverage of hormone therapy1, Pfizer Inc. today released important facts and context to respond to the newspaper’s account. Pfizer believes the coverage is based on a misleading and selective reading of both the science and history of hormone therapy (HT) medicines.

14 Dec 2009

CTRC-AACR San Antonio Breast Cancer Symposium presents new data on emerging breast cancer therapies

Breast cancer continues to be a dynamic field of research, and the CTRC-AACR San Antonio Breast Cancer Symposium, now in its 32nd year, is the premier destination to present new data on emerging therapies.

14 Dec 2009

Maine-based EMHS recognized for creating system-wide culture of safety

A poor economy in a rural area might seem like overwhelming obstacles to creating a sophisticated culture of safety in a health care system that serves the largest aging population in the country, but leaders at Eastern Maine Healthcare Systems (EMHS) beat those odds in 2009.

14 Dec 2009

Researchers present new data for diagnosis and management of beast cancer

As therapies for breast cancer continue to emerge, the issues of how to best monitor success and gauge prognosis remain important questions.

14 Dec 2009

Anthropologists create framework for measuring nutrition and health in violence-prone regions

For nearly two decades, Ivy Pike, an associate professor of anthropology at the University of Arizona, has been studying ethnic groups in rural northern Kenya to understand how violence shapes the health of those eking out a living there.

14 Dec 2009

Diabetic patients exposed to insulin glargine have higher incidence of cancer, shows study

Type 2 diabetes and obesity are linked to an increased risk of certain cancers. Recently published studies suggested that insulin glargine (a synthetic insulin preparation marketed under the trade name Lantus), may be associated with a higher risk of certain cancers than other insulins or oral glucose lowering medications.

14 Dec 2009

At the Crossroads: A guide to Alzheimer’s disease, dementia and driving

Every 70 seconds, someone develops Alzheimer’s disease.¹ In conjunction with National Older Driver Safety Awareness Week, Dec. 6-12, leading researchers are joining forces to encourage families to talk openly with loved ones about driving as soon as they are diagnosed with a form of dementia.

14 Dec 2009

UCB offers tips for managing rheumatoid arthritis during festive season

A third of women living with rheumatoid arthritis say their disease impacts their enjoyment of the festive season - Women living with rheumatoid arthritis find shopping for gifts, preparing holiday food, writing cards and wrapping presents most difficult to do - Nearly two thirds of women living with rheumatoid arthritis experience pain daily

14 Dec 2009

Physician's counsel can make a difference in reducing sudden death syndrome

The advice of a pediatrician to place infants on their backs to sleep appears to be the single most important motivator in getting parents to follow these recommendations and a key reason that the rate of sudden death syndrome (SIDS) has plummeted since the "Back to Sleep" campaign was launched in 1994, says a UT Southwestern researcher.

14 Dec 2009

Tulane Cancer Center starts randomizing patients in phase III clinical study of Alpharadin

Algeta ASA, the cancer therapeutics company, announces that the first clinical center in the US, the Tulane Cancer Center, New Orleans, has started randomizing patients in the phase III clinical study of Alpharadin in men with castration-resistant (also known as hormone-refractory) prostate cancer (CRPC) that has metastasized to the skeleton.

14 Dec 2009

Combination therapy improves overall survival in women with advanced breast cancer

In a clinical study, women with an aggressive form of breast cancer experienced a median survival of 14 months when treated with an investigational combination of TYKERB® (lapatinib) plus HERCEPTIN® (trastuzumab). The results of the Phase III study in HER2-positive metastatic breast cancer were presented during the 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held in San Antonio, Texas (Dec. 9 - 13).

14 Dec 2009

Black women with HR-positive breast cancer have worse disease-free and overall survival, shows data

Black women with hormone receptor (HR)-positive breast cancer had worse disease-free and overall survival, according to data presented at the CTRC-AACR Annual San Antonio Breast Cancer Symposium, held Dec. 9-13, 2009.

14 Dec 2009

National Vaccine Plan aims to protect Americans from vaccine-preventable illnesses

While vaccines help prevent many diseases in the United States, we lack immunization protection against several serious illnesses, says a new report from the Institute of Medicine that identifies priority areas for updating the National Vaccine Plan.

14 Dec 2009

Combination of Herceptin and chemotherapy improves treatment for women with HER2+ breast cancer

Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.

14 Dec 2009

NICE guidelines limit options for low cost osteoporosis drugs

Low cost osteoporosis drugs are strictly rationed for the under 75s, and UK physicians hampered by restrictive guidelines, according to findings which appear today in the journal Therapeutic Advances in Musculoskeletal Disease, published by SAGE.

14 Dec 2009

Wiley-Blackwell announces the launch of Essential Evidence

International STMS publisher Wiley-Blackwell today announced the launch of Essential Evidence, a new product added to its online, evidence-based content resource Essential Evidence Plus.

14 Dec 2009

Case Western Reserve University grants option to startup Thermalin Diabetes

Case Western Reserve University has granted an 18-month, exclusive option to startup Thermalin Diabetes Inc. regarding a portfolio of insulin analogs. The company must reach certain milestones in order to exercise its option to obtain an exclusive license on therapies designed to help patients with diabetes.

14 Dec 2009

Medicine News and Research

Psychopharmacology expert calls for more mental health staffing at army bases

MHI launches new research program in heart failure

Genentech announces Phase III study of Avastin in women treated with chemotherapy for advanced breast cancer

Hormone therapy: An important treatment option for post-menopausal women

CTRC-AACR San Antonio Breast Cancer Symposium presents new data on emerging breast cancer therapies

Maine-based EMHS recognized for creating system-wide culture of safety

Researchers present new data for diagnosis and management of beast cancer

Anthropologists create framework for measuring nutrition and health in violence-prone regions

Diabetic patients exposed to insulin glargine have higher incidence of cancer, shows study

At the Crossroads: A guide to Alzheimer’s disease, dementia and driving

UCB offers tips for managing rheumatoid arthritis during festive season

Physician's counsel can make a difference in reducing sudden death syndrome

Tulane Cancer Center starts randomizing patients in phase III clinical study of Alpharadin

Combination therapy improves overall survival in women with advanced breast cancer

Black women with HR-positive breast cancer have worse disease-free and overall survival, shows data

National Vaccine Plan aims to protect Americans from vaccine-preventable illnesses

Combination of Herceptin and chemotherapy improves treatment for women with HER2+ breast cancer

NICE guidelines limit options for low cost osteoporosis drugs

Wiley-Blackwell announces the launch of Essential Evidence

Case Western Reserve University grants option to startup Thermalin Diabetes

Everything there is to know about biosimilars eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News